FMC
23
-3
AIZ
82
2
INTU
58
-3
MS
77
-2
SYF
86
-6
KHC
9
-4
EXPD
43
-4
MAS
52
-4
ETR
65
2
EFX
30
-8
MSFT
48
-9
WBA
43
-4
REGN
38
-2
CSCO
58
-2
AMZN
61
-5
BK
74
3
AEP
54
6
VRTX
47
-6
HBI
58
3
YUM
43
-6
FMC
23
-3
AIZ
82
2
INTU
58
-3
MS
77
-2
SYF
86
-6
KHC
9
-4
EXPD
43
-4
MAS
52
-4
ETR
65
2
EFX
30
-8
MSFT
48
-9
WBA
43
-4
REGN
38
-2
CSCO
58
-2
AMZN
61
-5
BK
74
3
AEP
54
6
VRTX
47
-6
HBI
58
3
YUM
43
-6
Financhill
Back

JHancock Mortgage Backed Sec ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
82

JHMB
JHancock Mortgage Backed Sec ETF

Last Price:
21.62
Seasonality Move:
1.48%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
82
JHancock Mortgage Backed Sec ETF (JHMB) is a Buy

Is JHancock Mortgage Backed Sec ETF a Buy, Sell or Hold?

  • The current JHancock Mortgage Backed Sec ETF [JHMB] share price is $21.64. The Score for JHMB is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • JHMB is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JHMB Stock Price Chart

What is JHancock Mortgage Backed Sec ETF's stock price today?

  • The JHancock Mortgage Backed Sec ETF share price today is $21.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JHMB is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

JHMB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 37.5 Sell
Chaikin Money Flow: 2253 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.65 - 21.97) Sell
Bollinger Bands (100): (21.7 - 22.36) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

JHMB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.68 Sell
20-day SMA: 21.74 Sell
50-day SMA: 22.1 Sell
200-day SMA: 21.73 Sell
8-day EMA: 21.68 Sell
20-day EMA: 21.77 Sell
50-day EMA: 21.94 Sell
200-day EMA: 21.79 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

JHancock Mortgage Backed Sec ETF Earnings Growth & JHMB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

JHancock Mortgage Backed Sec ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):